577 related articles for article (PubMed ID: 16183692)
1. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
Lenzen MJ; Boersma E; Reimer WJ; Balk AH; Komajda M; Swedberg K; Follath F; Jimenez-Navarro M; Simoons ML; Cleland JG
Eur Heart J; 2005 Dec; 26(24):2706-13. PubMed ID: 16183692
[TBL] [Abstract][Full Text] [Related]
2. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure.
Masoudi FA; Havranek EP; Wolfe P; Gross CP; Rathore SS; Steiner JF; Ordin DL; Krumholz HM
Am Heart J; 2003 Aug; 146(2):250-7. PubMed ID: 12891192
[TBL] [Abstract][Full Text] [Related]
3. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
[TBL] [Abstract][Full Text] [Related]
4. Adherence to guidelines for patients hospitalized with heart failure: a nationwide survey.
Jotkowitz AB; Porath A; Shotan A; Mittelman M; Grossman E; Zimlichman R; Lewis BS; Caspi A; Gottlieb S; Garty M;
Isr Med Assoc J; 2006 Dec; 8(12):875-9. PubMed ID: 17214110
[TBL] [Abstract][Full Text] [Related]
5. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
Jost A; Rauch B; Hochadel M; Winkler R; Schneider S; Jacobs M; Kilkowski C; Kilkowski A; Lorenz H; Muth K; Zugck C; Remppis A; Haass M; Senges J;
Eur Heart J; 2005 Dec; 26(24):2689-97. PubMed ID: 16183697
[TBL] [Abstract][Full Text] [Related]
6. An approach to heart failure and diabetes mellitus.
Fonarow GC
Am J Cardiol; 2005 Aug; 96(4A):47E-52E. PubMed ID: 16098844
[TBL] [Abstract][Full Text] [Related]
7. Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.
Fonarow GC; Gheorghiade M; Abraham WT
Am J Cardiol; 2004 Nov; 94(9):1155-60. PubMed ID: 15518610
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers].
Kubota T; Takeshita A
Nihon Rinsho; 2003 May; 61(5):801-6. PubMed ID: 12755006
[TBL] [Abstract][Full Text] [Related]
10. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.
Juurlink DN; Mamdani MM; Lee DS; Kopp A; Austin PC; Laupacis A; Redelmeier DA
N Engl J Med; 2004 Aug; 351(6):543-51. PubMed ID: 15295047
[TBL] [Abstract][Full Text] [Related]
11. Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year.
Houpe D; Peltier M; Cohen-Solal A; Béguin M; Lévy F; Slama M; Chapelain K; Tribouilloy C
Int J Cardiol; 2005 Sep; 103(3):286-92. PubMed ID: 16098391
[TBL] [Abstract][Full Text] [Related]
12. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.
Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Gheorghiade M; Inge PJ; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
Circ Heart Fail; 2010 Sep; 3(5):596-605. PubMed ID: 20634483
[TBL] [Abstract][Full Text] [Related]
13. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure).
Krantz MJ; Ambardekar AV; Kaltenbach L; Hernandez AF; Heidenreich PA; Fonarow GC;
Am J Cardiol; 2011 Jun; 107(12):1818-23. PubMed ID: 21482418
[TBL] [Abstract][Full Text] [Related]
14. Spironolactone use in patients with heart failure.
Trujillo JM; Gonyeau MJ; DiVall MV; Alexander SL
J Clin Pharm Ther; 2004 Apr; 29(2):165-70. PubMed ID: 15068406
[TBL] [Abstract][Full Text] [Related]
15. beta-Blocker therapy in heart failure.
Doughty RN
Heart Fail Monit; 2000; 1(1):2-7. PubMed ID: 12634875
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological therapy of chronic heart failure in the elderly].
Sabbadini G; Di Lenarda A; Metra M; Nodari S; Moretti M; Brentana L; Dei Cas L; Sinagra G
Ital Heart J; 2004 Dec; 5 Suppl 10():37S-51S. PubMed ID: 15712511
[TBL] [Abstract][Full Text] [Related]
17. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
[TBL] [Abstract][Full Text] [Related]
18. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
Saha SA; Molnar J; Arora RR
Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
[TBL] [Abstract][Full Text] [Related]
19. Challenging the dogma of high target doses in the treatment of heart failure: is more always better?
Follath F
Arch Cardiovasc Dis; 2009 Nov; 102(11):785-9. PubMed ID: 19944395
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]